Skip Navigation
Explore our COVID-19 Resources and Updates
CHS blue logo square
 
 
Home > Our Work > All Publications > 2022

Publications

Our publications keep professionals informed on the most important developments and issues in health security and biosecurity.

Find an article or report by keywords:

 
 
Find an article or report or see all by area, author, or year:

Title:

A Closing Window of Opportunity for Gene Drive Governance in the United States

Authors:
Kelsey Lane Warmbrod, Michael Montague, and Gigi Kwik Gronvall
Date posted:
June 07, 2022
Publication type:
Article
Publication:
Health Secur. 2022 Jan-Feb;20(1):3-5
Publisher:
Mary Ann Liebert, Inc.
DOI:
10.1089/hs.2022.0009
See also:
Introduction:
The COVID-19 pandemic has brought forth a number of biotechnological advances to enhance the public's health: new diagnostic tests, mRNA vaccines, and new antiviral medications. Biotechnology is also being used to address global challenges like climate change, food insecurity, and building the bioeconomy, which directly or indirectly improve public health. Gene drives are one such biotechnology. They are genetically engineered systems that can alter the inheritance patterns in a host species, such as a mosquito, so that a greater percentage of its progeny inherit a specific desired trait. Research and investments in biotechnology have been used to reduce arthropod-borne infectious diseases, such as malaria and Zika, and to manage or eliminate invasive species.2 Funding thus far has been adequate. For example, Target Malaria, a global consortium of researchers developing a gene drive to decrease the burden of malaria, has an average of US$11.5 million per year in funding.3 Although no gene drive has been released into the environment yet, technologies with similar attributes have been released in field trials, notably by Oxitec in Florida.4

 

 

Our Mission

To protect people’s health from epidemics and disasters and ensure that communities are resilient to major challenges.